Table 1. Cell surface phenotypes of CSCs.
| Tumor type | Phenotype of CSCs markers | Reference |
|---|---|---|
| Leukemia | CD34+CD38−HLA-DR-CD71−CD90−CD117−CD123+ | 18 |
| Breast cancer | ESA+CD44+CD24−/lowLineage−, ALDH-1high | 4,20 |
| Liver cancer | CD133+, CD49f+, CD90+ | 21,22 |
| Brain cancer | CD133+, BCRP1+, A2B5+, SSEA-1+ | 19,23 |
| Lung cancer | CD133+, ABCG2high | 24,25 |
| Colon cancer | CD133+, CD44+, CD166+, EpCAM+, CD24+ | 26,27,28 |
| Multiple myeloma | CD138− | 29,30 |
| Prostate cancer | CD44+, α2β1high, CD133+ | 7 |
| Pancreatic | CD133+, CD44+, EpCAM+, CD24+ | 31,32 |
| Melanoma | CD20+ | 10 |
| Head and neck cancer | CD44+ | 33 |